Ara
Toplam kayıt 12, listelenen: 11-12
What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
(Aves, 2022)
Objective: Recommendations for the treatment of cytokine release syndrome/macrophage activation syndrome (MAS) associated with coronavirus disease-2019 (COVID-19) are still of poor quality. IL-6 is an important therapeutic ...
Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study
(Galenos Publ House, 2022)
Objective: Many methods are used in the treatment of coronavirus disease 2019 (COVID-19), which causes acute respiratory distress syndrome (ARDS), and there are conflicting reports in the literature regarding the results ...